Point72 Hong Kong’s Orphazyme A/S ORPH Stock Holding History

Point72 Hong Kong’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,817	Closed	-$40K	–	2503
2021 Q1	$40K	Buy	+4,817	New	+$59.3K	﹤0.01%	1333

Other funds holding ORPH

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BAM

Blueshift Asset Management Red Bank, New Jersey $432M AUM 13.14% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Hong Kong's ORPH Position: Q2 2021 in Review

Point72 Hong Kong sold out of Orphazyme A/S (ORPH) in Q2 2021, closing a stake of 4,817 shares — an estimated $40K sold.

Point72 Hong Kong first reported a position in ORPH in Q1 2021 and held it in 1 quarter. The position peaked at $40K in Q1 2021. 20 funds tracked by Wall St. Rank hold ORPH as of Q2 2021.

Point72 Hong Kong reported no remaining Orphazyme A/S position as of Q2 2021 after selling out during the quarter.
Point72 Hong Kong sold 4,817 Orphazyme A/S shares in Q2 2021, an estimated $40K.
Point72 Hong Kong first reported a position in Orphazyme A/S in Q1 2021 and held it in 1 quarter.
Point72 Hong Kong's Orphazyme A/S position peaked at $40K in Q1 2021.
20 funds tracked by Wall St. Rank held Orphazyme A/S as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.